Sie suchten nach: kawasaki (Englisch - Maltesisch)

kawasaki disease
il-marda ta’ kawasaki

patients with kawasaki disease.
pazjenti bil-marda ta’ kawasaki.

2 − guillain barré syndrome − kawasaki disease
2 immunomodulazzjoni − purpura tromboċitopenika idjopatika (itp), fi tfal jew adulti b' riskju għoli ta 'fsada jew qabel kirurġija sabiex jiġi korreġut l- għadd ta' plejtlits. − is- sindromu ta 'guillain barré − il- marda ta' kawasaki

uncommon: pallor (rare after booster) rare: kawasaki syndrome
mhux komuni: sfurija (rari wara l-booster) rari: is-sindrome ta' kawasaki

kawasaki disease, which causes multiple inflammations of several organs in the body.
il-marda kawasaki, li tikkawża infjammazzjonijiet multipli f’diversi organi fil-ġisem.

patients with a disease which results in multiple inflammations of several organs of the body (kawasaki disease).
pazjenti b’marda li tirriżulta f’infjammazzjonijiet multipli ta’ bosta organi tal-ġisem (il-marda ta’ kawasaki)

in addition, children with kawasaki disease are at especially high risk due to underlying cardiac compromise so dose and rate of administration should be carefully controlled.
barra minn hekk, tfal bil-marda ta’ kawasaki qegħdin f'riskju partikolarment għoli minħabba kompromess sottostanti tal-qalb u għalhekk id-doża u r-rata tal-għoti għandhom ikunu kkontrollati bir-reqqa.

it is used to treat kawasaki disease, an illness in children where the blood vessels (arteries) in the body become enlarged.
jintuża għall- kura tal- marda kawasaki, marda fit- tfal fejn il- vini (arterji) fil- ġisem jikbru.

during the 0-30 day follow-up period after vaccination, there were no statistically significant difference in the rate of kawasaki disease compared with the expected background rate.
waqt il-perjodu minn 0-30 jum ta’ segwitu wara t-tilqim, ma kien hemm l-ebda differenza statistikament sinifikanti fir-rata tal-marda ta’ kawasaki meta mqabbla mar-rata mistennija f’ambjent normali.

they can also be approved for the treatment of patients with guillain-barré syndrome, patients with kawasaki disease and patients undergoing a bone marrow transplant, without the need for specific studies in these diseases.
jistgħu jiġu approvati wkoll għat- trattament ta 'pazjenti bis- sindromu guillain- barré, pazjenti bil - marda ta' kawasaki u pazjenti li jkunu ħadu trapjant tal- mudullun, mingħajr il- ħtieġa għal studji speċifiċi għal dawn il- mardiet.

immunomodulation • immune thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. • guillain-barré syndrome. • kawasaki disease.
immunomodulazzjoni • purpura tromboċitopenika immuni (itp), fit- tfal jew fl- adulti li qegħdin f’ riskju għoli ta ’ ħruġ ta ’ demm, jew qabel operazzjoni biex l- għadd tal- plejtlits jiġi kkoreġut. • sindrome ta ’ guillain barré. • il- marda ta ’ kawasaki.